Prostate cancer and markers of bone metabolism: Diagnostic, prognostic, and therapeutic implications

Research output: Contribution to journalArticle

5 Scopus citations


Knowledge of bone metastases complicating advanced prostate cancer (CaP) is increasingly relevant in patient selection for novel therapies. Current nuclear bone scintigraphy imaging has limited specificity for prostate metastases. As serum bone markers do correlate with bony lesions, they may play multiple roles in patients with advanced CaP. Currently, these markers play a role in prognostic nomograms for CaP. Recent studies suggest an expanding role for bone markers in the diagnosis and selection of patients for novel therapies. In the future, therapeutic roles for some of these marker pathways will emerge, eventually allowing greater individualization of patient care.

Original languageEnglish (US)
Pages (from-to)393-399
Number of pages7
JournalWorld Journal of Urology
Issue number4
StatePublished - Aug 2007



  • Androgen-independent prostate cancer
  • Bone markers
  • Bone metastases
  • Osteoprotegerin
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this